WO2004033488A3 - Synthese de materiaux metalliques et magnetiques au moyen de peptides mediateurs - Google Patents

Synthese de materiaux metalliques et magnetiques au moyen de peptides mediateurs Download PDF

Info

Publication number
WO2004033488A3
WO2004033488A3 PCT/US2003/029555 US0329555W WO2004033488A3 WO 2004033488 A3 WO2004033488 A3 WO 2004033488A3 US 0329555 W US0329555 W US 0329555W WO 2004033488 A3 WO2004033488 A3 WO 2004033488A3
Authority
WO
WIPO (PCT)
Prior art keywords
metallic
magnetic materials
mediated synthesis
peptide mediated
magnectic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/029555
Other languages
English (en)
Other versions
WO2004033488A2 (fr
WO2004033488B1 (fr
Inventor
Angela M Belcher
Brian Reiss
Chuanbin Mao
Daniel Solis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Priority to CA002499318A priority Critical patent/CA2499318A1/fr
Priority to EP03796338A priority patent/EP1539342A2/fr
Priority to JP2004543323A priority patent/JP2006520317A/ja
Priority to AU2003298587A priority patent/AU2003298587A1/en
Publication of WO2004033488A2 publication Critical patent/WO2004033488A2/fr
Publication of WO2004033488A3 publication Critical patent/WO2004033488A3/fr
Publication of WO2004033488B1 publication Critical patent/WO2004033488B1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1866—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle the nanoparticle having a (super)(para)magnetic core coated or functionalised with a peptide, e.g. protein, polyamino acid
    • A61K49/1872—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle the nanoparticle having a (super)(para)magnetic core coated or functionalised with a peptide, e.g. protein, polyamino acid coated or functionalised with a polyamino acid, e.g. polylysine, polyglutamic acid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Powder Metallurgy (AREA)

Abstract

L'invention concerne des procédés permettant de produire des nanocristaux magnétiques en utilisant une molécule biologique qui a été modifiée de manière à posséder un oligomère d'acides aminés capable de se lier spécifiquement avec un matériau magnétique.
PCT/US2003/029555 2002-09-18 2003-09-22 Synthese de materiaux metalliques et magnetiques au moyen de peptides mediateurs Ceased WO2004033488A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002499318A CA2499318A1 (fr) 2002-09-18 2003-09-22 Synthese de materiaux metalliques et magnetiques au moyen de peptides mediateurs
EP03796338A EP1539342A2 (fr) 2002-09-18 2003-09-22 Synthese de materiaux metalliques et magnetiques au moyen de peptides mediateurs
JP2004543323A JP2006520317A (ja) 2002-09-18 2003-09-22 金属および磁性材料のペプチドを媒介した合成
AU2003298587A AU2003298587A1 (en) 2002-09-18 2003-09-22 Peptide mediated synthesis of metallic and magnetic materials

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41180402P 2002-09-18 2002-09-18
US60/411,804 2002-09-18

Publications (3)

Publication Number Publication Date
WO2004033488A2 WO2004033488A2 (fr) 2004-04-22
WO2004033488A3 true WO2004033488A3 (fr) 2004-10-07
WO2004033488B1 WO2004033488B1 (fr) 2005-01-20

Family

ID=32093766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/029555 Ceased WO2004033488A2 (fr) 2002-09-18 2003-09-22 Synthese de materiaux metalliques et magnetiques au moyen de peptides mediateurs

Country Status (7)

Country Link
EP (1) EP1539342A2 (fr)
JP (1) JP2006520317A (fr)
KR (1) KR20050043973A (fr)
CN (1) CN1753724A (fr)
AU (1) AU2003298587A1 (fr)
CA (1) CA2499318A1 (fr)
WO (1) WO2004033488A2 (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7304128B2 (en) * 2002-06-04 2007-12-04 E.I. Du Pont De Nemours And Company Carbon nanotube binding peptides
US7598344B2 (en) 2002-09-04 2009-10-06 Board Of Regents, The University Of Texas System Composition, method and use of bi-functional biomaterials
US20050064508A1 (en) 2003-09-22 2005-03-24 Semzyme Peptide mediated synthesis of metallic and magnetic materials
WO2004036992A2 (fr) * 2002-09-24 2004-05-06 Board Of Regents, University Of Texas System Dispositif de stockage de biofilms fabriques
GB0313259D0 (en) 2003-06-09 2003-07-16 Consejo Superior Investigacion Magnetic nanoparticles
AU2008202025B2 (en) * 2003-06-09 2011-03-31 Consejo Superior De Investigaciones Cientificas Magnetic nanoparticles
US7923109B2 (en) * 2004-01-05 2011-04-12 Board Of Regents, The University Of Texas System Inorganic nanowires
KR20070091608A (ko) * 2004-10-19 2007-09-11 매사추세츠 인스티튜트 오브 테크놀로지 결정체 결함의 생체분자 인식
US7687115B2 (en) 2004-11-24 2010-03-30 3M Innovative Properties Company Method for making nanostructured surfaces
US7582330B2 (en) 2004-11-24 2009-09-01 3M Innovative Properties Counsel Method for making metallic nanostructures
JP4558471B2 (ja) * 2004-12-14 2010-10-06 富士通株式会社 ナノ粒子およびナノ粒子の製造方法
US20070196305A1 (en) * 2005-03-01 2007-08-23 Hong Wang Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
JP4700374B2 (ja) * 2005-03-03 2011-06-15 学校法人東京理科大学 ＳｍＣｏ系磁性微粒子の製造方法
US7629027B2 (en) 2005-10-14 2009-12-08 3M Innovative Properties Company Method for making chromonic nanoparticles
US7718716B2 (en) 2005-10-14 2010-05-18 3M Innovative Properties Company Chromonic nanoparticles containing bioactive compounds
US7807661B2 (en) 2005-12-08 2010-10-05 3M Innovative Properties Company Silver ion releasing articles and methods of manufacture
US7601769B2 (en) 2005-12-19 2009-10-13 3M Innovative Peroperties Company Multilayered chromonic structures
US8092710B2 (en) 2005-12-19 2012-01-10 3M Innovative Properties Company Hierarchical chromonic structures
US7824732B2 (en) 2005-12-28 2010-11-02 3M Innovative Properties Company Encapsulated chromonic particles
KR100945433B1 (ko) * 2007-10-02 2010-03-05 광주과학기술원 도데카머 펩티드 마이다스-1 내지 마이다스-12를 이용한 금나노구조물의 합성 방법
DE102007056818A1 (de) * 2007-11-23 2009-05-28 Bayer Technology Services Gmbh Bakteriophagen und Beschichtungsmaterial für Oberflächen
KR101109124B1 (ko) * 2009-02-12 2012-02-16 한국과학기술연구원 박테리아 및 전이금속 산화물로 이루어진 유ㆍ무기 복합체 및 이의 제조방법
KR100945434B1 (ko) * 2009-04-21 2010-03-05 광주과학기술원 도데카머 펩티드 마이다스-1 내지 마이다스-12를 이용한 금 나노구조물의 합성 방법
CN101817091A (zh) * 2010-04-28 2010-09-01 燕山大学 一种以t4噬菌体为模板制备铁纳米磁性粒子的方法
EP2386355A1 (fr) * 2010-05-11 2011-11-16 Biorem Engineering SARL Alliages métalliques avec composant microbiologique et propriétés catalytiques
CN103118777B (zh) * 2010-05-24 2016-06-29 希路瑞亚技术公司 纳米线催化剂
CN103764276B (zh) 2011-05-24 2017-11-07 希路瑞亚技术公司 用于甲烷氧化偶合的催化剂
US20130158322A1 (en) 2011-11-29 2013-06-20 Siluria Technologies, Inc. Polymer templated nanowire catalysts
CA3092028C (fr) 2012-01-13 2022-08-30 Lummus Technology Llc Procede de separation de composes hydrocarbones
US9446397B2 (en) 2012-02-03 2016-09-20 Siluria Technologies, Inc. Method for isolation of nanomaterials
CA2874043C (fr) 2012-05-24 2021-09-14 Siluria Technologies, Inc. Formes et formulations catalytiques
EP2855005A2 (fr) 2012-05-24 2015-04-08 Siluria Technologies, Inc. Systèmes et procédés de couplage oxydant du méthane
US9969660B2 (en) 2012-07-09 2018-05-15 Siluria Technologies, Inc. Natural gas processing and systems
WO2014089479A1 (fr) 2012-12-07 2014-06-12 Siluria Technologies, Inc. Procédés et systèmes intégrés pour la conversion de méthane en de multiples produits hydrocarbonés supérieurs
WO2014143880A1 (fr) 2013-03-15 2014-09-18 Siluria Technologies, Inc. Catalyseurs pour une catalyse pétrochimique
US10047020B2 (en) 2013-11-27 2018-08-14 Siluria Technologies, Inc. Reactors and systems for oxidative coupling of methane
EP3092286A4 (fr) 2014-01-08 2017-08-09 Siluria Technologies, Inc. Systèmes et procédés de conversion d'éthylène en liquides
US10377682B2 (en) 2014-01-09 2019-08-13 Siluria Technologies, Inc. Reactors and systems for oxidative coupling of methane
CA2935946C (fr) 2014-01-09 2022-05-03 Siluria Technologies, Inc. Couplage oxydatif d'implementations methaniques pour la production d'olefines
WO2015168601A2 (fr) 2014-05-02 2015-11-05 Siluria Technologies, Inc. Catalyseurs hétérogènes
CN105467126B (zh) * 2014-09-09 2018-01-09 东北师范大学 一种用于检测白色念珠菌的噬菌体复合纳米线
HUE054014T2 (hu) 2014-09-17 2021-08-30 Lummus Technology Inc Katalizátorok metán oxidatív csatolására és etán oxidatív dehidrogenálására
US9334204B1 (en) 2015-03-17 2016-05-10 Siluria Technologies, Inc. Efficient oxidative coupling of methane processes and systems
US10793490B2 (en) 2015-03-17 2020-10-06 Lummus Technology Llc Oxidative coupling of methane methods and systems
US20160289143A1 (en) 2015-04-01 2016-10-06 Siluria Technologies, Inc. Advanced oxidative coupling of methane
US9328297B1 (en) 2015-06-16 2016-05-03 Siluria Technologies, Inc. Ethylene-to-liquids systems and methods
EP3786138A1 (fr) 2015-10-16 2021-03-03 Lummus Technology LLC Couplage oxidatif de méthane
EP3429747A2 (fr) 2016-03-16 2019-01-23 Siluria Technologies, Inc. Catalyseurs et procédés pour les traitements de gaz naturel
EP4071131A1 (fr) 2016-04-13 2022-10-12 Lummus Technology LLC Appareil et procédé d'échange de chaleur
WO2018118105A1 (fr) 2016-12-19 2018-06-28 Siluria Technologies, Inc. Procédés et systèmes pour effectuer des séparations chimiques
KR20200034961A (ko) 2017-05-23 2020-04-01 루머스 테크놀로지 엘엘씨 메탄의 산화적 커플링 공정의 통합
EP3649097A4 (fr) 2017-07-07 2021-03-24 Lummus Technology LLC Systèmes et procédés permettant le couplage oxydant de méthane
CA3127339A1 (fr) 2019-01-30 2020-08-06 Lummus Technology Llc Catalyseurs pour couplage oxydatif du methane
CN110095464B (zh) * 2019-04-12 2022-01-28 武汉科技大学 一种复杂组成的烧结矿矿相精细化定量分析方法
US12227466B2 (en) 2021-08-31 2025-02-18 Lummus Technology Llc Methods and systems for performing oxidative coupling of methane
CN115137824B (zh) * 2022-07-01 2023-06-30 哈尔滨工程大学 一种具有热效应的硅担载双金属材料的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003029431A2 (fr) * 2001-10-02 2003-04-10 Board Of Regents, University Of Texas System Ordonnancement a l'echelle nano de materiaux hybrides a l'aide de virus a l'echelle meso transformes par genie genetique.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003029431A2 (fr) * 2001-10-02 2003-04-10 Board Of Regents, University Of Texas System Ordonnancement a l'echelle nano de materiaux hybrides a l'aide de virus a l'echelle meso transformes par genie genetique.

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHUANBIN MAO ET AL: "viral assembly of oriented quantom dot nanowires", PNAS, vol. 100, no. 12, June 2003 (2003-06-01), pages 6946 - 6951, XP002288377 *
HAAPARANTA T ET AL: "A COMBINATORIAL METHOD FOR CONSTRUCTING LIBRARIES OF LONG PEPTIDES DISPLAYED BY FILAMENTOUS PHAGE", 1995, MOLECULAR DIVERSITY, ESCOM SCIENCE PUBLISHERS, LEIDEN, NL, PAGE(S) 39-52, ISSN: 1381-1991, XP009032871 *
LEE J ET AL: "LAYER-BY-LAYER GROWTH OF CDSE-BASED NANOCRYSTAL LIGHT-EMITTING DIODES", JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, AMERICAN SCIENTIFIC PUBLISHERS, US, vol. 1, no. 1, 2001, pages 59 - 64, XP009032870, ISSN: 1533-4880 *
NAIK R R ET AL: "BIOMIMETIC SYNTHESIS AND PATTERNING OF SILVER NANOPARTICLES", NATURE MATERIALS, NATURE PUBLISHING GROUP, LONDON, GB, vol. 1, no. 3, November 2002 (2002-11-01), pages 169 - 172, XP009032889, ISSN: 1476-4660 *
SEUNG-WUK LEE ET AL.: "ordering of quantum dots using genetically engeneered viruses", SCIENCE, vol. 296, May 2002 (2002-05-01), pages 892 - 895, XP002288378 *

Also Published As

Publication number Publication date
AU2003298587A1 (en) 2004-05-04
WO2004033488A2 (fr) 2004-04-22
CN1753724A (zh) 2006-03-29
WO2004033488B1 (fr) 2005-01-20
JP2006520317A (ja) 2006-09-07
CA2499318A1 (fr) 2004-04-22
KR20050043973A (ko) 2005-05-11
EP1539342A2 (fr) 2005-06-15

Similar Documents

Publication Publication Date Title
WO2004033488A3 (fr) Synthese de materiaux metalliques et magnetiques au moyen de peptides mediateurs
CA2155335A1 (fr) Methode amelioree pour le repliage de proteines
EP1225193A3 (fr) Compositions pour la préparation de formes de matériaux finement divisés
CA2175797A1 (fr) Proteases inhibitrices humaines de type kunitz
SI2230299T1 (sl) Nov citokinski zcytor ligand
MY130026A (en) Peptide inhibitors of mitogenesis and motogenesis.
EP1624065A3 (fr) Agarase et gène correspondant
AU2003298523A1 (en) Methods for efficient production of mammalian recombinant proteins
WO2003008449A8 (fr) Ntb-a, une molecule de surface impliquee dans l'activite des cellules tueuses naturelles
WO2004005920A3 (fr) Procede pour enrichir et pour depister des proteines prions pathologiques modifiees (prpsc)
DE60331437D1 (de) Nachspaltige sulfurentschützung zur konvergenten proteinherstellung beim verfahren von chemischer ligation
WO2002020541A3 (fr) Methode de production de plusieurs oligonucleotides sur un support solide
AU2003229761A1 (en) Peptide variants of ige constrained by beta-lactam bond
WO2006104695A3 (fr) Procede de separation entre marqueur libre a effet raman et bio-essai ou autre melange de reaction
IL184080A (en) Synthesis of peptide t-20 using peptide intermediate fragments
AU6134596A (en) Enamel matrix related polypeptide
WO2007100358A3 (fr) Synthèse convergente de protéines par ligature à cinétique contrôlée
EP1321517A3 (fr) Enzyme 2-cétoreductase de Gluconobacter oxydans et ses applications
EP0855388A3 (fr) Procédé de production d'intermédiaires utiles dans la synthese d'inhibiteurs de proteases rétrovirales
WO2003025179A1 (fr) Nouveau polypeptide, adn associe et utilisation de ce polypeptide
WO2003083099A3 (fr) Nouveaux polypeptides purifies impliques dans la synthese et la modification des proteines
WO2003044185A3 (fr) Nouveaux polypeptides purifies iimpliques dans un metabolisme general
WO2002029054A1 (fr) Nouvelle proteine, son procede de production et son utilisation
WO2003040292A3 (fr) Genes codant pour des proteines de synthese membranaire et de transport membranaire
WO2003061596A3 (fr) Procedes et reactifs servant a generer des supports de peptides seriques chimeres

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
B Later publication of amended claims

Effective date: 20040929

WWE Wipo information: entry into national phase

Ref document number: 2499318

Country of ref document: CA

Ref document number: 1020057004559

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2004543323

Country of ref document: JP

Ref document number: 20038222264

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2003796338

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003298587

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1020057004559

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003796338

Country of ref document: EP